Latest Videos

Video List based on Category on Node Page

Latest Videos

Yohannes Ghebre (Baylor College of Medicine, Houston, TX, US) discusses the rationale and clinical evidence to date for using proton pump inhibitors (PPIs) to treat idiopathic pulmonary fibrosis (IPF). Questions 1. What are the limitations of the currently approved drugs, pirfenidone and...
The FDA has fast-tracked Ofev and Esbriet as approved medications for IPF. Together with stem cell therapy, we're closer to finding a cure for IPF.
Dr. Aryeh Fischer discusses highlights of a session held at the 2015 ATS annual conference which focused on several topics related to the management of ILD and related diseases. In addition, he discusses the announcement of a new disease classification, 'interstitial pneumonia with autoimmune...

Interstitial Lung Disease INSIGHTS

The touchRESPIRATORY website provides a selection of resources to inform clinicians and patients about the latest developments in the field. The following are quick, non peer-reviewed, opinion-based updates addressing current trends and opinion on the most recent advances in the area of respiratory medicine:

Insight
Highlights from the ATS International Congress 2018— Focus on IPF Alex Lowe, Senior Medical Writer, Touch Medical Media, UK
Shanker Krishna, Account Director and Advisory Editor, Touch Medical Media, UK
Insights into IPF research presented at American Thoracic Society International Congress, San Diego, CA, US, May 18–23, 2018.
Insight
Highlights from the ERS International Congress 2017: focus on idiopathic pulmonary fibrosis Katrina Mountfort, Senior Medical Writer, Touch Medical Media, UK
Matthew Goodwin, Respiratory Business Unit Director, Touch Medical Media, UK